Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration.

Cell death in neurodegenerative diseases is often thought to be governed by apoptosis; however, an increasing body of evidence suggests the involvement of alternative cell death mechanisms in neuronal degeneration. We studied retinal neurodegeneration using 10 different animal models, covering all major groups of hereditary human blindness (rd1, rd2, rd10, Cngb1 KO, Rho KO, S334ter, P23H, Cnga3 KO, cpfl1, Rpe65 KO), by investigating metabolic processes relevant for different forms of cell death. We show that apoptosis plays only a minor role in the inherited forms of retinal neurodegeneration studied, where instead, a non-apoptotic degenerative mechanism common to all mutants is of major importance.

Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.

Retinitis pigmentosa (RP) is a severe retinal disease characterized by a progressive degeneration of rod photoreceptors and a secondary loss of cone function. Here, we used CNGB1-deficient (CNGB1(-/-)) mice, a mouse model for autosomal recessive RP, to evaluate the efficacy of adeno-associated virus (AAV) vector-mediated gene therapy for the treatment of RP. The treatment restored normal expression of rod CNG channels and rod-driven light responses in the CNGB1(-/-) retina.

Characterization of neurite outgrowth and ectopic synaptogenesis in response to photoreceptor dysfunction.

In the mammalian retina, light signals generated in photoreceptors are passed to bipolar and horizontal cells via synaptic contacts. In various pathological conditions, these second-order neurons extend neurites into the outer nuclear layer (ONL). However, the molecular events associated with this neurite outgrowth are not known.

Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.

Retinitis pigmentosa (RP) is a group of genetically heterogeneous, severe retinal diseases commonly leading to legal blindness. Mutations in the CNGB1a subunit of the rod cyclic nucleotide-gated (CNG) channel have been found to cause RP in patients. Here, we demonstrate the efficacy of gene therapy as a potential treatment for RP by means of recombinant adeno-associated viral (AAV) vectors in the CNGB1 knockout (CNGB1(-/-)) mouse model.

Toward a high-rate enhanced biological phosphorus removal process in a membrane-assisted bioreactor.

A membrane enhanced biological phosphorus removal (MEBPR) process was studied to determine the impact of hydraulic retention time (HRT) and solids retention time (SRT) on the removal of chemical oxygen demand (COD), nitrogen, and phosphorus from municipal wastewater. The MEBPR process was capable of delivering complete nitrification independent of the prevailing operating conditions, whereas a significant improvement in COD removal efficiency was observed at longer SRTs. In the absence of carbon-limiting conditions, the MEBPR process was able to achieve low phosphorus concentrations in the effluent at increasingly higher hydraulic loads, with the lowest HRT being 5 hours.

Methods and techniques for the selective extraction and recovery of oxoanions.

An important goal in environmental chemistry is the extraction of metals that are toxic or radioactive from soils and waters. For many such metals, the problem is solved by designing compounds with coordination sites that are specific for that particular metal. For cases such as oxoanions, however, where the inorganic center is already fully coordinated by oxygens, different strategies need to be used.